Brian Henry

Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule?

Brian Henry, Christopher J. Foti, Karen M. Alsante · Journal of Photochemistry and Photobiology B Biology · 2009 · 1.9K citations

Photosafety Risks, Health Sciences, Ophthalmology +12

Characterization of Enhanced Behavioral Responses tol-DOPA Following Repeated Administration in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

Brian Henry, Alan R. Crossman, Jonathan M. Brotchie · Experimental Neurology · 1998 · 187 citations

Neurophysiology, Behavioral Neuroscience, Medicine +9

Characterisation of human saliva as a platform for oral dissolution medium development

Sally Gittings, Neil Turnbull, Brian Henry et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2015 · 168 citations · Full text

Engineering, Human Saliva, Oral Cavity +10

Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease

Susan H. Fox, Brian Henry, Michael P. Hill et al. · Movement Disorders · 2002 · 162 citations

Effect of Repeatedl-DOPA, Bromocriptine, or Lisuride Administration on Preproenkephalin-A and Preproenkephalin-B mRNA Levels in the Striatum of the 6-Hydroxydopamine-Lesioned Rat

Brian Henry, Alan R. Crossman, Jonathan M. Brotchie · Experimental Neurology · 1999 · 157 citations

Medicine, Neuropharmacology, Preproenkephalin-b Mrna Levels +7